Tandem Diabetes Care (TNDM) Stock Price, Quote & News

Company Profile

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 366 6900

Website: www.tandemdiabetes.com

Address:

12400 High Bluff Drive, San Diego, United States

JamesTaulman Aug. 19 at 3:11 AM

TUE 8/18: $TNDM – BUYING (1/3) @ $23.49 3:31 PM – Picking up a 1/3 position in this Medical-Products company as shares advance from the 10 DMA on a 24% increase in daily volume. The stock also appears capable of closing above the previous high near $23.80, which would provide another bullish technical confirmation. There has not been much to choose from recently as both the market and individual stocks have remained relatively quiet during this mid-summer stretch following the peak of earnings season. TNDM stands out as one of the more promising opportunities currently showing the type of price-and-volume action that could produce some upside potential. James’ Trader’s Tip: Selectivity Matters in Quiet Markets • When fewer stocks are producing quality technical signals, there is no reason to force trades. • Focus on the names that continue to show clear support, improving volume, and bullish price action. • Quiet markets reward patience—and make the strongest individual opportunities stand out even more. https://buyingbreakouts.com/tue-8-18-tndm-buying-1-3-23-49/

0 · Reply

JFDI Aug. 18 at 2:08 PM

$TNDM

0 · Reply

Therow Aug. 17 at 3:49 AM

$FIVN $TNDM I like the market cap on these names vs relative peers. Both charts are showing strength after catalysts. FIVN is the higher-quality growth story with AI momentum, but it’s more extended. TNDM has more of a “turnaround/re-acceleration” feel and still sits further from its highs. If you’re trading them, the key levels to watch are: • FIVN: support in the $29–30 area, resistance near the recent high. • TNDM: support around $20–21, next resistance toward $25–26. Both have momentum on their side for now.

0 · Reply

JInvestTrade Aug. 14 at 1:25 AM

$ABT $DXCM $PODD $SENS $TNDM

1 · Reply

JInvestTrade Aug. 14 at 1:13 AM

$SENS $DXCM $ABT $TNDM $PODD https://lnkd.in/p/gUqQAkEB

0 · Reply

labibaouf Aug. 11 at 6:54 PM

$TNDM been listening to the call really great company to invest in now.

0 · Reply

deepthinker Aug. 11 at 6:34 PM

$MODD So, $TNDM and $PODD are struggling with T2 while. $BBNX is doing well with T2 despite no indication. Why? Same reason as CeQur: simplicity. Here we have Pivot that is a simple device, a T2 targeted device really, and no one wants to own it? Weird.

1 · Reply

BriOnH Aug. 11 at 3:54 PM

$SANA $ELDN $DXCM $PODD $TNDM Fellow T1D Investors, this is more of a very exciting PSA to us T1D's than an investing opportunity as Endo Axium is not publicly traded. It is an Australian based company I have been following for a couple years now. They are beginning testing on an oral insulin that is encapsulated in glucose responsive nanoparticles, meaning as blood sugar rises, the nanoparticles release insulin, in humans. I listed their peer review a while back, and they had normoglycemia, meaning no hypos or high bs, in baboons (or maybe gorillas, or something like that I forget off the top of my head). For us T1D's this potentially means just swallowing a pill every 3 days and forgetting we even have T1D! Let's hope it works!!! Even more exciting Sana's SC451 should be entering ph1/2 in the next coming months!!! We have so much good stuff coming!!!!! LFG!!!

4 · Reply

JamieJJ Aug. 10 at 12:09 PM

$TNDM The huge green candle confirmed the strong uptrend and momentum, let's ride it.

0 · Reply

Steve_TheBull_Rogers Aug. 7 at 6:44 PM

$TNDM ALL OUT HERE AT 21.95 LIMIT SELL Nearly 100% ROE SWING TRADE NICE WORK SUBS

0 · Reply

Tandem Diabetes Care Transcript: Canaccord Genuity's 46th Annual Growth Conference

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Tandem Diabetes Care Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Tandem Diabetes Care Slides: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Tandem Diabetes Care Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Tandem Diabetes Care Quarterly report: Q2 2026

Aug 6, 2026, 4:05 PM EDT - 12 days ago

Market Cap	1.55B
Revenue (ttm)	1.01B
Net Income (ttm)	-204.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-20.17%
Debt to Equity Ratio	0.00

Volume	2,631,300
Avg Vol	2,131,282
Day's Range	N/A - N/A
Shares Out	69.58M
Stochastic %K	95%
Beta	1.53
Analysts	Sell
Price Target	$29.18